OXA-548

........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270.......280.......290..... MRSFAISTVLVMSSLLASSIIAAPTFASTAVKKEWQETRSWDAIFTQHQAEPQQAKL-----QKTKLQQTSGVVALWNENKQQGYTNNLKRANQGFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGKSRDIATWNRDHNLITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNEDISGNLDSFWLDGGIRISATEQIDFLRRLYYNKIHASERSQRIVKQAMLTEANSDYIIRAKTGYAVRAEPSIGWWVGWIELDDNVWFFAMNMDIPDAAGLPLRQAITKEVLKLEHVIP

OXA-549	..........G......................................V.......-----...................................................................................................................T.............................H..V............................................V.......................................	97.93 %
OXA-550	.................................................V.......-----......................................................................V......S...................................................................................................................V.......................................	98.62 %
OXA-551	...................T..........A.T................V......QQQAKP....S..A....V....................................E...............................................................................................H...............................................V...N...................................	94.24 %
OXA-552	.................................................V.......-----...................................................................................................................T.............................H..V............................................V.......................................	98.28 %
OXA-553	.................................................V......QQQAKP....S....................................................................................................................................................................................................................................	97.29 %

Last updated: November 20, 2024.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since December 3rd, 2023)